查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1308671

到 2030 年肠道疾病检测市场预测 - 按病原体、技术、最终用户和地区进行的全球分析

Enteric Disease Testing Market Forecasts to 2030 - Global Analysis By Pathogen, Technology (Traditional, Rapid, Convenience Based, Polymerase Chain Reaction, Immunoassay, Chromatography & Spectrometry & Other Technologies), End User & By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球肠道疾病检测市场规模将达到 41.8 亿美元，预测期内復合年增长率为 8%，到 20.3 亿美元将达到 71.6 亿美元。

胃肠道感染，包括胃、小肠和大肠，被称为肠病。 细菌、病毒和寄生虫等微生物可以引起这些疾病。 艰难梭菌(C. difficile)、弯曲桿菌、霍乱、大肠桿菌、幽门螺桿菌(H. pylori)、沙门氏菌病、痢疾、诺如病毒、轮状病毒、阿米巴病、隐孢子虫病、贾第鞭毛虫病等是肠道疾病的典型例子。

根据世界卫生组织 (WHO) 2020 年 5 月发布的一份报告，食物中毒对于幼儿来说尤其严重。 报告称，腹泻病是不安全食品引起的最常见疾病，每年影响5.5亿人，其中2.2亿是五岁以下儿童。

市场动态：

驱动程序：

方便食品的需求增加

忙碌的生活方式正在逐渐将客户的兴趣从传统的生食转移到方便包装的食品，例如冷冻食品和即食食品 (RTE)。 为了提高适销性，化学品被用来增强食品和饮料的有机特性。 然而，包装产品中也使用防腐剂来延长保质期。

抑製剂

成本高

由于其广泛的功能和特性，自动化检测设备非常昂贵。 例如，基于光谱的系统成本在 150,000 美元到 850,000 美元之间。 估计设备、介质和劳动力成本也可能非常高，具体取决于最终用户。

机会：

技术进步

整个供应链的技术发展和创新改变了业务开展方式。 重点是缩短交货时间、样品利用率并降低所提供测试服务的总体成本。 更便宜、更快速、更高效的计算技术与改进的软件、网络连接和智能传感器相结合，在肠道疾病市场中越来越受欢迎。

威胁

缺乏适当的监管

欠发达国家的食品企业仍然高度分散，由小型、无组织的公司主导，这些公司可能没有执行基本的食品检测标准，并构成很高的污染风险。 食品和饮料产品检测，包括包装食品、乳製品、饮料和肉类产品，需要适当的执行机制、市场参与者之间的协调和配套基础设施。 然而，新兴经济体的许多国家缺乏这些变量，限制了这些地区食品和水的病原体检测。

新冠肺炎 (COVID-19) 影响：

在 COVID-19 大流行期间，人们担心病毒和细菌污染，并选择自製清洁食品。 因此，感染率有所下降，2020 年和 2021 年进行的检测数量也有所下降。 在大流行期间，COVID-19 检测优先于所有其他传染病检测。 因此，疫情期间肠道疾病检测试剂盒的需求减少，阻碍了市场增长。

在预测期内，食品领域预计将是最大的：

在预测期内，随着食品贸易、公共卫生和政府组织的扩大，需要定期检查食品质量，并立即采取行动识别、遏制和纠正疫情来源，预计食品行业将占所占份额最大。 例如，肠道疾病控制服务局 (FSIS) 制定了基于 HACCP 肠道疾病控制系统的法规，以限制屠宰场和加工厂的肉类和家禽产品污染。

预计快速技术领域在预测期内的复合年增长率最高：

快速技术领域预计在预测期内将出现良好增长。 在食品工业中，用于监测引起食品腐败、储存、发酵、安全和食物中毒的微生物的数量、类型和代谢物。 危害分析和关键控制点(HACCP) 模型和其他肠道疾病系统的使用已牢牢扎根于质量保证和质量控制(QA/QC) 计划中，也有助于确保测试“更快、更好、更好”。行业对廉价实时结果的需求也不断增长。

份额最大的地区：

北美将在 2022 年主导肠道疾病检测市场，并将在预测期内继续占据主导地位。 该地区拥有Abbott Laboratories、Becton Dickinson & Company、Biomerica, Inc、Bio-Rad Laboratories, Inc、Meridian Bioscience, Inc、Quest Diagnostics等几大公司，以及肠道疾病检测产品的製造技术也是先进的，正在推动市场的增长。 这主要是由于肠道疾病患者数量的增加、政府对肠道疾病诊断研究的资助增加以及发达国家资本收入的大幅增加。

复合年增长率最高的地区：

该地区大肠桿菌、沙门氏菌病、霍乱、幽门螺桿菌等传染性肠道疾病患病率不断增加，中国、印度等人口大国购买力不断增强，预计太平洋地区在肠道疾病检测市场的预测期内以最高速度增长。 此外，有吸引力的市场区域位于中国和印度等增长国家，推动亚太地区增长最快。 由于检测意识的增强和疾病的增加，预计亚太地区将发展最快。

主要进展

2022 年 1 月，Meridian Bioscience Inc. 宣布 Curian Campy 检测获得美国食品和药物管理局 (FDA) 批准。 Curian Campy 检测是一种快速定性荧光免疫检测，用于检测人类粪便样本中的弯曲桿菌特异性抗原，包括空肠弯曲桿菌、大肠桿菌、乌普萨拉弯曲桿菌和拉里弯曲桿菌。 该检测方法专为与 Curian 的免疫荧光测试平台一起使用而开发。

2020 年 1 月，Biomerieux SA 宣布其分子生物学子公司 BioFire Diagnostics 已向美国食品和药物管理局申请其 BIOFIRE 血培养鑑定 2 (BCID2) 小组的 510(k) 许可。 与现有的 BIOFIRE BCID 组合相比，BIOFIRE BCID2 组合包括几种额外的病原体、扩大的抗菌素耐药基因列表和许多修订的目标。

本报告的内容

  • 区域和国家级市场份额评估
  • 给新进入者的战略建议
  • 2021 年、2022 年、2023 年、2026 年和 2030 年的综合市场数据
  • 市场趋势（促进因素、阻碍因素、机遇、威胁、挑战、投资机会、建议）
  • 根据市场预测提出关键业务领域的战略建议
  • 竞争格局绘製主要共同趋势
  • 公司简介，包括详细的战略、财务状况和最新发展
  • 供应链趋势映射最新技术趋势

免费定制服务：

订阅此报告的客户将获得以下免费自定义选项之一：

  • 公司简介
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要公司的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家/地区的市场估计/预测/复合年增长率（注：基于可行性检查）
  • 竞争基准测试
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第二章前言

  • 概述
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源

第三章市场趋势分析

  • 驱动程序
  • 制约因素
  • 机会
  • 威胁
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新冠肺炎 (COVID-19) 的影响

第 4 章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间存在敌对关係

第五章全球肠道疾病检测市场：按病原体分类

  • 弯曲桿菌
  • 梭状芽胞桿菌
  • 大肠桿菌
  • 肠桿菌科
  • 甲型、乙型、戊型肝炎
  • 单核细胞增生李斯特氏菌
  • 诺如病毒
  • 轮状病毒
  • 沙门氏菌
  • 金黄色葡萄球菌
  • 弧菌
  • 其他病原体

第六章全球肠道疾病检测市场：按技术分类

  • 传统
  • 快
  • 便利基地
  • 聚合□炼式反应 (PCR)
  • 免疫分析
  • 色谱和光谱分析
  • 其他技术

第 7 章：全球肠道疾病检测市场：按最终用户划分

  • 水
  • 食物
    • 肉类、家禽、海鲜
    • 乳製品
    • 加工食品
    • 水果和蔬菜
    • 坚果、香草和香料
    • 谷物和谷物
    • 其他食物
  • 其他最终用户

第 8 章：全球肠道疾病检测市场：按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 亚太地区其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东和非洲地区

第 9 章主要进展

  • 合同、伙伴关係、协作和合资企业
  • 收购与合併
  • 推出新产品
  • 业务扩展
  • 其他关键策略

第 10 章公司简介

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • SGS SA
  • Eurofins Scientific
  • Bureau Veritas
  • Intertek
  • Romer Labs
  • Merieux NutriSciences
  • TUV SUD
  • PerkinElmer, Inc
  • Becton Dickinson
  • Certified Laboratories
  • ALS Limited
  • Neogen Corporation
  • Hardy Diagnostics
Product Code: SMRC23371

According to Stratistics MRC, the Global Enteric Disease Testing Market is accounted for $4.18 billion in 2023 and is expected to reach $7.16 billion by 2030 growing at a CAGR of 8% during the forecast period. Infections of the gastrointestinal tract, including the stomach, small intestine, and large intestine, are known as enteric diseases. Microorganisms such as bacteria, viruses, and parasites can cause these disorders. Clostridium difficile (C. difficile), campylobacteriosis, cholera, Escherichia coli (E. coli), Helicobacter pylori (H. pylori), salmonellosis, shigellosis, norovirus, rotavirus, amebiasis, cryptosporidiosis, and giardiasis are some typical instances of enteric disorders.

According to the World Health Organization (WHO) report published in May 2020, foodborne diseases can be severe, especially for young children. According to the same source, diarrheal diseases are the most common illnesses resulting from unsafe food, with 550 million people falling ill yearly, of which 220 million are children under the age of 5 years.

Market Dynamics:

Driver:

Increase in demand for convenience foods

Busy lives have gradually altered customer focus away from traditional raw food purchases and toward convenience and packaged foods such as frozen foods and ready-to-eat (RTE) meals. To increase marketability, chemicals are employed to enhance the organoleptic properties of food and beverages. However, preservatives are also applied to packaged products to extend their shelf life.

Restraint:

High cost

Automated testing instruments are expensive because they include extensive features and functions. The cost of spectroscopy-based systems, for example, ranges from USD 150,000 to USD 850,000. For some end users, the estimated cost of the instrument, media, and labor is also very high.

Opportunity:

Technological advancements

Technological developments and innovation throughout the supply chain have changed the way business operates. The emphasis is on decreasing lead time, sample utilization, and the overall cost of testing services provided. In the enteric illness market, cheaper, faster, and more efficient computing technology, combined with improved software, network connectivity, and smart sensors, is gaining attraction.

Threat:

Lack of proper regulations

The food business in underdeveloped nations is still extremely fragmented, dominated by small and unorganized firms that may not have implemented basic food testing standards, posing a higher risk of contamination. Food and beverage product testing, such as packaged foods, dairy products, beverages, and meat products, necessitates appropriate enforcement mechanisms, coordination among market parties, and supporting infrastructure. However, many nations in the developing economies cluster lack these variables, limiting pathogen testing in food and water in these locations.

COVID-19 Impact:

People were concerned about viral and bacterial contamination during the COVID-19 pandemic, so they opted for home-cooked or clean cuisine. This resulted in a decreased infection rate and a decrease in the number of tests performed in 2020 and 2021. Also, during the pandemic, COVID-19 testing took precedence over all other infectious disease testing; hence, demand for enteric illness testing kits decreased during the pandemic, hampering market growth.

The food segment is expected to be the largest during the forecast period:

Food segment is expected to hold largest share throughout the projected period with the expansion of the food trade, public health, and government organizations have been driven to regularly check food quality and take immediate action to identify, contain, and correct outbreak origins. For example, the Enteric Disease and Inspection Service (FSIS) has developed regulations based on the HACCP enteric disease control system to limit the contamination of meat and poultry products in slaughterhouses and processing plants.

The rapid technology segment is expected to have the highest CAGR during the forecast period:

Rapid technology segment is expected to have lucrative growth during the forecasted period. It is used in the food industry to monitor the number, type, and metabolites of microorganisms that cause food spoilage, preservation, fermentation, safety, and foodborne pathogens. The use of the Hazard Analysis and Critical Control Points (HACCP) model and other enteric disease systems has become firmly entrenched in quality assurance and quality control (QA/QC) programs, as has the industry's requirement for "faster, better, cheaper" real-time results from tests.

Region with largest share:

North America dominated the enteric disease testing market in 2022 and is likely to continue to do so during the forecast period. The presence of several major players in the region, such as Abbott Laboratories, Becton Dickinson & Company, Biomerica, Inc., Bio-Rad Laboratories, Inc., Meridian Bioscience, Inc., and Quest Diagnostics, as well as advancements in the manufacturing technology of enteric disease testing products, drive the market's growth. This is mostly due to an increase in the number of people suffering from enteric diseases, an increase in government financing for enteric disease diagnosis research, and a considerable increase in capital income in industrialized nations.

Region with highest CAGR:

Due to an increase in the prevalence of infectious enteric diseases such as E. coli, salmonellosis, cholera, and H. pylori in this region, as well as growth in the purchasing power of populated countries such as China and India, Asia-Pacific is expected to grow at the highest pace during the enteric disease testing market forecast period. Additionally, attractive market regions are located in growing countries such as China and India, driving Asia Pacific's most rapid growth. Asia-Pacific is predicted to develop most rapidly, owing to increased testing awareness and rising ailments.

Key players in the market

Some of the key players in Enteric Disease Testing market include Merck KGaA , Thermo Fisher Scientific Inc., SGS SA, Eurofins Scientific, Bureau Veritas, Intertek, Romer Labs, Merieux NutriSciences, TUV SUD, PerkinElmer, Inc, Becton Dickinson, Certified Laboratories, ALS Limited, Neogen Corporation and Hardy Diagnostics.

Key Developments:

In January 2022, Meridian Bioscience Inc. announced that the Curian Campy assay has received U.S. Food and Drug Administration (FDA) clearance. The Curian Campy assay is a rapid, qualitative fluorescent immunoassay for the detection of a Campylobacter-specific antigen including C. jejuni, C. coli, C. upsaliensis, and C. lari in human fecal specimens. The assay was developed to be utilized on the Curian immunofluorescent testing platform.

In January 2020, Biomerieux SA announced that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clearance of the BIOFIRE Blood Culture Identification 2 (BCID2) Panel. The BIOFIRE BCID2 Panel includes several additional pathogens, an expanded list of antimicrobial resistance genes, and many revised targets compared to the existing BIOFIRE BCID Panel.

Pathogens Covered:

  • Campylobacter
  • Clostridium
  • E. coli
  • Enterobacteriaceae
  • Hepatitis A, B, and E
  • Listeria
  • Norovirus
  • Rotavirus
  • Salmonella
  • Shigella
  • Vibrio
  • Other Pathogens

Technologies Covered:

  • Traditional
  • Rapid
  • Convenience Based
  • Polymerase Chain Reaction (PCR)
  • Immunoassay
  • Chromatography & Spectrometry
  • Other Technologies

End Users Covered:

  • Water
  • Food
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Enteric Disease Testing Market, By Pathogen

  • 5.1 Introduction
  • 5.2 Campylobacter
  • 5.3 Clostridium
  • 5.4 E. coli
  • 5.5 Enterobacteriaceae
  • 5.6 Hepatitis A, B, and E
  • 5.7 Listeria
  • 5.8 Norovirus
  • 5.9 Rotavirus
  • 5.10 Salmonella
  • 5.11 Shigella
  • 5.12 Vibrio
  • 5.13 Other Pathogens

6 Global Enteric Disease Testing Market, By Technology

  • 6.1 Introduction
  • 6.2 Traditional
  • 6.3 Rapid
  • 6.4 Convenience Based
  • 6.5 Polymerase Chain Reaction (PCR)
  • 6.6 Immunoassay
  • 6.7 Chromatography & Spectrometry
  • 6.8 Other Technologies

7 Global Enteric Disease Testing Market, By End User

  • 7.1 Introduction
  • 7.2 Water
  • 7.3 Food
    • 7.3.1 Meat, Poultry and Seafood
    • 7.3.2 Dairy Products
    • 7.3.3 Processed Food
    • 7.3.4 Fruits & Vegetables
    • 7.3.5 Nuts, Herbs & Spices
    • 7.3.6 Cereals & Grains
    • 7.3.7 Other Foods
  • 7.4 Other End Users

8 Global Enteric Disease Testing Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Merck KGaA
  • 10.2 Thermo Fisher Scientific Inc.
  • 10.3 SGS SA
  • 10.4 Eurofins Scientific
  • 10.5 Bureau Veritas
  • 10.6 Intertek
  • 10.7 Romer Labs
  • 10.8 Merieux NutriSciences
  • 10.9 TUV SUD
  • 10.10 PerkinElmer, Inc
  • 10.11 Becton Dickinson
  • 10.12 Certified Laboratories
  • 10.13 ALS Limited
  • 10.14 Neogen Corporation
  • 10.15 Hardy Diagnostics

List of Tables

  • Table 1 Global Enteric Disease Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Enteric Disease Testing Market Outlook, By Pathogen (2021-2030) ($MN)
  • Table 3 Global Enteric Disease Testing Market Outlook, By Campylobacter (2021-2030) ($MN)
  • Table 4 Global Enteric Disease Testing Market Outlook, By Clostridium (2021-2030) ($MN)
  • Table 5 Global Enteric Disease Testing Market Outlook, By E. coli (2021-2030) ($MN)
  • Table 6 Global Enteric Disease Testing Market Outlook, By Enterobacteriaceae (2021-2030) ($MN)
  • Table 7 Global Enteric Disease Testing Market Outlook, By Hepatitis A, B, and E (2021-2030) ($MN)
  • Table 8 Global Enteric Disease Testing Market Outlook, By Listeria (2021-2030) ($MN)
  • Table 9 Global Enteric Disease Testing Market Outlook, By Norovirus (2021-2030) ($MN)
  • Table 10 Global Enteric Disease Testing Market Outlook, By Rotavirus (2021-2030) ($MN)
  • Table 11 Global Enteric Disease Testing Market Outlook, By Salmonella (2021-2030) ($MN)
  • Table 12 Global Enteric Disease Testing Market Outlook, By Shigella (2021-2030) ($MN)
  • Table 13 Global Enteric Disease Testing Market Outlook, By Vibrio (2021-2030) ($MN)
  • Table 14 Global Enteric Disease Testing Market Outlook, By Other Pathogens (2021-2030) ($MN)
  • Table 15 Global Enteric Disease Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 16 Global Enteric Disease Testing Market Outlook, By Traditional (2021-2030) ($MN)
  • Table 17 Global Enteric Disease Testing Market Outlook, By Rapid (2021-2030) ($MN)
  • Table 18 Global Enteric Disease Testing Market Outlook, By Convenience Based (2021-2030) ($MN)
  • Table 19 Global Enteric Disease Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
  • Table 20 Global Enteric Disease Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
  • Table 21 Global Enteric Disease Testing Market Outlook, By Chromatography & Spectrometry (2021-2030) ($MN)
  • Table 22 Global Enteric Disease Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 23 Global Enteric Disease Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Enteric Disease Testing Market Outlook, By Water (2021-2030) ($MN)
  • Table 25 Global Enteric Disease Testing Market Outlook, By Food (2021-2030) ($MN)
  • Table 26 Global Enteric Disease Testing Market Outlook, By Meat, Poultry and Seafood (2021-2030) ($MN)
  • Table 27 Global Enteric Disease Testing Market Outlook, By Dairy Products (2021-2030) ($MN)
  • Table 28 Global Enteric Disease Testing Market Outlook, By Processed Food (2021-2030) ($MN)
  • Table 29 Global Enteric Disease Testing Market Outlook, By Fruits & Vegetables (2021-2030) ($MN)
  • Table 30 Global Enteric Disease Testing Market Outlook, By Nuts, Herbs & Spices (2021-2030) ($MN)
  • Table 31 Global Enteric Disease Testing Market Outlook, By Cereals & Grains (2021-2030) ($MN)
  • Table 32 Global Enteric Disease Testing Market Outlook, By Other Foods (2021-2030) ($MN)
  • Table 33 Global Enteric Disease Testing Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.